|
Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Ability Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda |
Research Funding - Pfizer (Inst); Roche (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche |
|
|
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche |
Expert Testimony - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; Roche; Takeda |
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche; Takeda |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda; Tesaro |
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Helsinn Healthcare |
Research Funding - Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche |
|
|
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche |
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche |
|
|
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche |
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche |
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Roche |
Research Funding - Merck Serono |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |
|
|
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Pierre Fabre |
Consulting or Advisory Role - Boehringer Ingelheim |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb |
Expert Testimony - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche |
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Pfizer; Roche |
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Janssen; Merck Sharp & Dohme; Roche |